ArticlebioRxiv : the preprint server for biology2026
The ChIP-FRiP pipeline quantifies co-binding and reveals how antibody background contributes to cohesin ChIP-seq patterns.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Quantitative interpretation of ChIP-seq data is instrumental to derive insight into chromatin and transcription factor biology. Here we developed ChIP-FRiP, an end-to-end pipeline enabling systematic comparison of pairwise protein positioning, and applied it to the study of cohesin. In mammalian interphase, loop extruding cohesin complexes are positioned by CTCF barriers to generate locus-specific 3D genome folding patterns. Many aspects of our understanding of cohesin loop extrusion come from interpreting the amount of cohesin ChIP-seq signal at CTCF barriers, which has been reported to change variably after perturbing cohesin co-factors, such as NIPBL, PDS5A/B, and WAPL. Using ChIP-FRiP to homogeneously process 140 cohesin ChIP-seq datasets from 13 publicly available studies, we observed substantial variation attributable to technical effects, obscuring biological interpretability. To better understand how technical considerations, such as antibody specificity, influence apparent cohesin binding patterns, we integrated technical aspects of ChIP-seq into biophysical simulations of loop extrusion. Leveraging a simple biochemical model for background ChIP-seq signal, we derived a strategy to estimate and correct for the background using paired spike-in ChIP-seq data from wild-type and depletion conditions. Our results establish a framework for reliable comparative analysis, demonstrating that accurate background correction is requisite for interpreting the roles of cohesin cofactors in cohesin positioning.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.